LivaNova

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LivaNova and other ETFs, options, and stocks.

About LIVN

LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the following segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support (ACS). 

CEO
Vladimir A. Makatsaria
CEOVladimir A. Makatsaria
Employees
2,900
Employees2,900
Headquarters
London, Greater London
HeadquartersLondon, Greater London
Founded
2015
Founded2015
Employees
2,900
Employees2,900

LIVN Key Statistics

Market cap
3.49B
Market cap3.49B
Price-Earnings ratio
-15.93
Price-Earnings ratio-15.93
Dividend yield
Dividend yield
Average volume
621.52K
Average volume621.52K
High today
$64.18
High today$64.18
Low today
$62.56
Low today$62.56
Open price
$63.18
Open price$63.18
Volume
484.00K
Volume484.00K
52 Week high
$64.31
52 Week high$64.31
52 Week low
$32.48
52 Week low$32.48

Stock Snapshot

LivaNova(LIVN) stock is priced at $63.90, giving the company a market capitalization of 3.49B. It carries a P/E multiple of -15.93.

On 2025-12-04, LivaNova(LIVN) stock traded between a low of $62.56 and a high of $64.18. Shares are currently priced at $63.90, which is +2.1% above the low and -0.4% below the high.

The LivaNova(LIVN)'s current trading volume is 484K, compared to an average daily volume of 621.52K.

During the past year, LivaNova(LIVN) stock moved between $32.48 at its lowest and $64.31 at its peak.

During the past year, LivaNova(LIVN) stock moved between $32.48 at its lowest and $64.31 at its peak.

LIVN News

Simply Wall St 4d
LivaNova Is Up 5.5% After Medicare Boosts VNS Therapy Reimbursement—Has the Bull Case Changed?

In November 2025, LivaNova PLC announced that the U.S. Centers for Medicare & Medicaid Services reassigned VNS Therapy™ for drug-resistant epilepsy to a new pay...

LivaNova Is Up 5.5% After Medicare Boosts VNS Therapy Reimbursement—Has the Bull Case Changed?

Analyst ratings

70%

of 10 ratings
Buy
70%
Hold
30%
Sell
0%

People also own

Based on the portfolios of people who own LIVN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.